Dignitana AB Publishes January Newsletter
(REGULATORY) Dignitana Announces the Outcome of the Rights Issue and the Directed Issues
(REGULATORY) Dignitana offentliggör utfallet för företrädesemissionen och de riktade emissionerna
(REGULATORY) Dignitana Partners with ThermoTek to Develop Next Generation in Scalp Cooling
Dignitana AB Publishes December Newsletter
(REGULATORY) Dignitana complements the previously announced directed rights issue – decides on an additional directed rights issue
(REGULATORY) Dignitana kompletterar den tidigare aviserade riktade emissionen med ytterligare en riktad emission
Dignitana AB Publishes Information Memorandum
Dignitana offentliggör Informations-Memorandum
(REGULATORY) Dignitana AB (Publ) Announces Rights Issue and Directed Equity Issue
(REGULATORY) Dignitana AB (Publ) Genomför Företrädesemission Och Riktad Nyemission
(REGULATORY) Dignitana AB Publishes Q3 Interim Report
(REGULATORY) DigniCap Clinical Trial Launched at Beijing University Cancer Hospital
Dignitana AB Publishes November Newsletter
Dignitana AB Announces Change of Publication Date for Third Quarter 2018 Interim Report
Dignitana AB Publishes October Newsletter
(REGULATORY) Dignitana AB Announces Major New Shareholder
Dignitana AB Publishes September Newsletter
Dignitana CEO William Cronin to Speak at Aktiespararna Event in Stockholm
(REGULATORY) Dignitana AB Publishes Interim Report for Q2 2018
(REGULATORY) Dignitana AB publicerar delårsrapport för Q2 2018
Dignitana AB Publishes August Newsletter
(REGULATORY) DIGNITANA GROWS BUSINESS IN ITALY
(REGULATORY) DIGNITANA VÄXER I ITALIEN och startar dotterbolag
Dignitana Publishes July Newsletter
(REGULATORY) DIGNITANA KOMMENTERAR AMERICAN MEDICAL ASSOCIATION (DET AMERIKANSKA LÄKARFÖRBUNDET) BESLUT ATT INTE INFÖR EN UNIK CPT® CODE FÖR KYLNING AV HÅRBOTTEN
(REGULATORY) DIGNITANA RESPONDS TO AMERICAN MEDICAL ASSOCIATION DECISION REGARDING UNIQUE CPT CODE FOR SCALP COOLING
Dignitana Publishes June Newsletter
(REGULATORY) Dignitana publishes Interim Financial Report for Q1 2018
Dignitana Publishes May Newsletter
Dignitana Launches Survey to Gather Critical Insights on Insurance Coverage and Reimbursement for Cancer Patients Undergoing Chemotherapy
(REGULATORY) Communication from the Dignitana AB Annual General Meeting 2018
(REGULATORY) Sysmex Europe GmbH to Transfer Management of All European Installations Of The DigniCap Scalp Cooling System Back to Dignitana AB
(REGULATORY) Dignitana Publishes Annual Report for 2017
(REGULATORY) Notice of Annual General Meeting in Dignitana AB (publ) – correction
(REGULATORY) Notice of Annual General Meeting in Dignitana AB (publ)
(REGULATORY) Dignitana AB: Report from Extraordinary Shareholders Meeting on 16 March 2018
Dignitana Initiates Action with American Medical Association to Add CPT® Codes for Insurance Coverage of FDA-Cleared Scalp Cooling Medical Devices
(REGULATORY) Dignitana, Inc. Appoints Three Board Members in U.S. And Names James McKinney President and Chief Operating Officer
(REGULATORY) Notice of extraordinary shareholders meeting in Dignitana AB (publ)
(REGULATORY) Dignitana Announces Changes to Board of Directors
(REGULATORY) Dignitana Publishes Year End Financial Report 2017
Dignitana to Present Live Facebook Session to “Aktier – Småbolagsjakten” on February 28
(REGULATORY) The new share issue in Dignitana was fully subscribed and the company received SEK 42.6 million
(REGULATORY) Nyemissionen i Dignitana tecknades fullt ut och bolaget tillförs 42,6 MSEK
(REGULATORY) Dignitana publishes prospectus
(REGULATORY) Dignitana offentliggör prospekt
(REGULATORY) DIGNITANA LAUNCHES WORLD’S FIRST PRECISION-FIT SCALP COOLING CAP
(REGULATORY) DIGNITANA LANSERAR VÄRLDENS FÖRSTA PRECISIONSANPASSADE SKALPKYLNINGSMÖSSA
(REGULATORY) DIGNITANA GROWTH CONTINUES IN U.S. WITH RWJ BARNABAS HEALTH AND THREE MORE CENTERS
(REGULATORY) DIGNITANA FORTSÄTTER VÄXA I USA MED RWJ BARNABAS HEALTH OCH TRE ANDRA KLINIKER
(REGULATORY) DIGNITANA TO EXHIBIT DIGNICAP® SCALP COOLING SYSTEM AT 2017 SAN ANTONIO BREAST CANCER SYMPOSIUM
(REGULATORY) DIGNITANA STÄLLER UT DIGNICAP® SCALP COOLING SYSTEM PÅ SAN ANTONIO BRÖSTCANCERSYMPOSIUM 2017
(REGULATORY) Dignitana: Kommuniké från extra bolagsstämma 2017-12-04
(REGULATORY) Dignitana publish interim financial report for Q3, 2017
(REGULATORY) Dignitana AB publicerar delårsrapport för Q3 – 2017
(REGULATORY) DIGNITANA APPOINTS WILLIAM CRONIN AS NEW CEO
(REGULATORY) DIGNITANA UTSER WILLIAM CRONIN TILL NY VD
(REGULATORY) RÄTTELSE AV KALLELSE TILL EXTRASTÄMMA I DIGNITANA AB (publ)
(REGULATORY) Rättelse i pressmeddelande 2017-11-02 ”Dignitana beslutar om företrädesemission om 42,6 MSEK”
(REGULATORY) DIGNITANA FLYTTAR VERKSAMHETEN TILL USA
(REGULATORY) DIGNITANA MOVING OPERATIONS TO THE U.S.
(REGULATORY) Kallelse till extra bolagsstämma i Dignitana AB (publ)
(REGULATORY) Dignitana beslutar om företrädesemission om 42,6 MSEK
(REGULATORY) Dignitana decides on a Rights Issue of 42.6 MSEK
(REGULATORY) CHANGES IN DIGNITANA’S FINANCING
(REGULATORY) FÖRÄNDRINGAR I DIGNITANAS FINANSIERING
(REGULATORY) DIGNITANA CONTINUES U.S. GROWTH WITH EIGHT NEW LOCATIONS
(REGULATORY) DIGNITANA FORTSÄTTER VÄXA I USA MED ÅTTA NYA AVTAL
(REGULATORY) DIGNITANA FÖRTYDLIGAR BOLAGETS STÄLLNING
(REGULATORY) DIGNITANA CLARIFIES THE COMPANY’S POSITION
(REGULATORY) DIGNITANA FORTSÄTTER ATT VÄXA I USA OCH LANSERAR INTEGRATIONSPROGRAM
(REGULATORY) DIGNITANA CONTINUES U.S. GROWTH AND LAUNCHES INTEGRATION PROGRAM
(REGULATORY) DIGNITANA REVISES 2017 PROJECTIONS FOLLOWING PRODUCTION DELAYS
(REGULATORY) DIGNITANA REVIDERAR FÖRSÄLJNINGSPROGNOS EFTER PRODUKTIONSFÖRSENINGAR
(REGULATORY) DIGNITANA ESTABLISHES CREDIT FACILITY TO SUPPORT INCREASED DEMAND
(REGULATORY) DIGNITANA TAR UPP LÅN FÖR ATT MÖTA ÖKAD EFTERFRÅGAN
(REGULATORY) Dignitana publish interim financial report for Q2, 2017
(REGULATORY) Dignitana AB publicerar delårsrapport för Q2 – 2017
(REGULATORY) Dignitana ger ut teckningsoptioner
(REGULATORY) DIGNITANA GÖR AVTAL MED VÅRDNÄTVERKET DIGNITY HEALTH – TILLVÄXTEN FORTSÄTTER I USA
(REGULATORY) DIGNITANA SIGNS ON DIGNITY HEALTH AS GROWTH CONTINUES IN U.S.
(REGULATORY) CHANGES TO THE BOARD OF DIRECTORS AT DIGNITANA
(REGULATORY) FÖRÄNDRINGAR I DIGNITANAS STYRELSE
(REGULATORY) DIGNITANA FORTSÄTTER VÄXA I USA – TECKNAR TIO NYA AVTAL
(REGULATORY) DIGNITANA CONTINUES U.S. GROWTH WITH TEN NEW ORDERS
(REGULATORY) FDA EXPANDS DIGNICAP CLEARANCE IN U.S. TO SOLID TUMOR CANCERS
(REGULATORY) FDA GER UTÖKAT GODKÄNNANDE FÖR DIGNICAP® I USA – OMFATTAR NU SOLIDA CANCERTUMÖRER
(REGULATORY) FDA DECISION TRIPLES DIGNITANA U.S. MARKET SIZE
(REGULATORY) FDA-BESLUT ÖPPNAR FÖR KRAFTIGT ÖKAD MARKNAD FÖR DIGNITANA I USA
(REGULATORY) DIGNITANA MEDICAL ADVISORS HELP LAUNCH INTERNATIONAL SCALP COOLING COLLABORATION AMONG TOP CANCER CENTERS WORLDWIDE
DIGNITANA MEDICAL ADVISORS HELP LAUNCH INTERNATIONAL SCALP COOLINGCOLLABORATION AMONG TOP CANCER CENTERS WORLDWIDE
(REGULATORY) DIGNITANA PARTNERS WITH PIEDMONT CANCER INSTITUTE TO HELP GEORGIA BREAST CANCER PATIENTS KEEP THEIR HAIR
(REGULATORY) DIGNITANA INGÅR SAMARBETE MED PIEDMONT CANCER INSTITUTE FÖR ATT HJÄLPA BRÖSTCANCERPATIENTER I GEORGIA ATT BEHÅLLA HÅRET
(REGULATORY) Kommuniké från årsstämma 2017
(REGULATORY) Dignitana AB publicerar delårsrapport för Q1 – 2017
(REGULATORY) Dignitana publish interim financial report for Q1, 2017
DIGNITANA CONTINUES AUGMENTED GROWTH ACROSS THE U.S.
(REGULATORY) DIGNITANA CONTINUES AUGMENTED GROWTH ACROSS THE U.S.
(REGULATORY) Dignitana AB publicerar årsredovisningen för 2016
(REGULATORY) Kallelse till årsstämma i Dignitana AB (publ)
(REGULATORY) PROMINENT MEDICAL CENTER PARTNERS WITH THE HOME OF THE KENTUCKY DERBY TO RAISE FUNDS FOR THE DIGNICAP SYSTEM
PROMINENT MEDICAL CENTER PARTNERS WITH THE HOME OF THE KENTUCKY DERBY TO RAISE FUNDS FOR THE DIGNICAP SYSTEM
DIGNITANA CONTINUES EXPONENTIAL GROWTH ACROSS THE U.S.
(REGULATORY) Dignitana publishes Year End Financial Report 2016
DIGNITANA FUELS GROWTH WITH NINE NEW INSTALLATIONS IN U.S. FOR DigniCap® SCALP COOLING MEDICAL DEVICE
MEMORIAL SLOAN KETTERING TO OFFER DIGNICAP® SCALP COOLING DEVICE IN NEW YORK METRO AREA LOCATIONS
DIGNITANA LAUNCHES DIGNICAP® MOBILE APP FOR U.S. PATIENTS
DIGNITANA CELEBRATES FIRST ANNIVERSARY OF FDA CLEARANCE FOR DIGNICAP® SYSTEM AT SAN ANTONIO BREAST CANCER SYMPOSIUM
DIGNITANA PARTNERS WITH BOA TECHNOLOGY TO DEVELOP THE WORLD’S FIRST PRECISION-FIT SCALP COOLING CAP
(REGULATORY) Dignitana AB publish interim financial report for Q3, 2016
DIGNITANA AB NAMES TOP TECH ENGINEER JOHAN ERICSSON AS CHIEF EXECUTIVE OFFICER AND EXPANDS U.S. LEADERSHIP TEAM
DIGNITANA AB LANDS THREE KEY CONTRACTS IN U.S.FOR DIGNICAP® SCALP COOLING MEDICAL DEVICE, FUELING GROWTH IN FOURTH QUARTER
ADDITIONAL SOUTHERN CALIFORNIA BREAST HEALTH CENTERS ADD DIGNICAP® TO THEIR PATIENT TREATMENT OFFERINGS
DIGNITANA TEAMS UP WITH FORMER QUARTERBACK PEYTON MANNING AND THE CANCER BEAT TO HELP WOMEN WITH BREAST CANCER REDUCE HAIR LOSS
(REGULATORY) Dignitana AB publish interim financial report for Q2 2016
DEMAND FOR DIGNICAP® SYSTEM REMAINS STRONG AS 32 U.S. MEDICAL CENTERS ADD DIGNITANA’S SCALP COOLING DEVICE TO THEIR CANCER CARE SERVICES
DEMAND FOR DIGNICAP® IS STRONG AS DIGNITANA BRINGS FDA-CLEARED MEDICAL SCALP COOLING DEVICE TO MORE U.S. CANCER CENTERS
(REGULATORY) FDA-CLEARED DIGNICAP® SCALP COOLING SYSTEM COMES TO THREE MORE U.S. CANCER TREATMENT CENTERS
(REGULATORY) FDA-CLEARED DIGNICAP® SCALP COOLING SYSTEM IS NOW AVAILABLE FOR WOMEN WITH BREAST CANCER AT 10 U.S. CANCER TREATMENT CENTERS
(REGULATORY) Dignitana publishes Year End Financial Report 2015
(REGULATORY) Dignitana Receives U.S. FDA De Novo Clearance for The DigniCap® Scalp Cooling System
(REGULATORY) Dignitana publish interim financial report for Q3 2015
(REGULATORY) Dignitana obtains patent in the United States of America
(REGULATORY) Dignitana To Exhibit DigniCap® at San Antonio Breast Cancer Symposium
Dignitana Announces Private Placement Offering
(REGULATORY) Dignitana offentliggör prospekt
(REGULATORY) Förändringar i styrelsen
(REGULATORY) Dignitana AB publicerar delårsrapport för Q3 2014
(REGULATORY) Dignitana AB genomför företrädesemission om 16,9 MSEK
Bitarna på plats inför en bredare kommersialisering
Deloitte ranks Dignitana AB as one of the fastest growing technology companies
(REGULATORY) Deloitte rankar Dignitana AB som ett av Sveriges snabbast växande teknologiföretag
(REGULATORY) Dignitana i möte med Food and Drug Administration (FDA)
(REGULATORY) Sysmex övertar den brittiska marknaden
(REGULATORY) Dignitanas medicinteknik ett steg närmare USA-marknaden
(REGULATORY) Dignitana – delårsrapport Q2 – 2014
(REGULATORY) Dignitana tar prestigeorder i England
(REGULATORY) Dignitana AB har inkluderat samtliga patienter i den pågående studien för FDA godkännande i USA
Dignitana Completes Patient Recruitment in a Multi-Center Pivotal Trial for FDA approval in the United States
(REGULATORY) Fördelning av anskaffningsutgift för aktier i Dignitana AB och BrainCool AB
(REGULATORY) Utvalda sjukhus i Kina börjar behandla med DigniCap®
(REGULATORY) Dignitana AB publicerar delårsrapport för Q1 2014
(REGULATORY) Slutlig sammanräkning i Dignitana AB:s företrädesemission
(REGULATORY) Dignitana AB:s företrädesemission övertecknad
(REGULATORY) Samarbete med University of Edinburgh och organisationsförstärkning
(REGULATORY) Researchers Gather at The Royal Marsden
(REGULATORY) Offentliggörande av prospekt för Dignitana AB:s företrädesemission
(REGULATORY) Dignitana genomför nyemission om 35 MSEK för fortsatt snabb tillväxt och satsning på brain cool verksamheten
(REGULATORY) Dignitana Delårsrapport Q2 2012
(REGULATORY) PartnerTech tecknar samarbetsavtal med Dignitana AB (publ)
(REGULATORY) PartnerTech signs framework agreement with Dignitana AB (publ)
(REGULATORY) Dignitana: Kommuniké från årsstämma 2012
(REGULATORY) Breakthrough for DigniCap™
(REGULATORY) Kallelse till årsstämma i Dignitana AB(publ)
(REGULATORY) Avtal med partner i Chile och order om fyra system
(REGULATORY) Delårsrapport januari-mars 2012
(REGULATORY) Dignitana erhåller order om tio (10) DigniCap system
(REGULATORY) Komplettering av bokslutskommuniké
(REGULATORY) Stororder i samband med samarbetsavtal med Europeisk industriell partner
(REGULATORY) Semmy Rülf tillträder Dignitanas styrelse
(REGULATORY) Tecknar distributionsavtal med HDX Corporation för Vietnam
(REGULATORY) Multicenter clinical trial for hypothermia treatment of stroke patients obtain funding of MEUR 15
(REGULATORY) VD intervju samt uppföljning av kapitalmarknadsdag LifeScience dagen 7 mars
(REGULATORY) DIGNITANA – dotterbolagsinformation Brain Cool AB
(REGULATORY) Bokslutskommuniké 2011
(REGULATORY) Pressrelease